RHUMBLINE ADVISERS - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 59 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$586,276
-18.5%
56,537
+12.6%
0.00%0.0%
Q2 2023$718,935
+307137.2%
50,205
+53.2%
0.00%
Q1 2023$234
-32.2%
32,761
+6.6%
0.00%
Q4 2022$345
-99.9%
30,732
+6.2%
0.00%
Q3 2022$321,000
+42.7%
28,927
+8.5%
0.00%
Q2 2022$225,000
-17.3%
26,649
+33.5%
0.00%
Q1 2022$272,000
-19.5%
19,968
+16.0%
0.00%
Q4 2021$338,000
-39.6%
17,207
-1.4%
0.00%
-100.0%
Q3 2021$560,000
+0.7%
17,454
+6.2%
0.00%0.0%
Q2 2021$556,000
+29.9%
16,438
+44.3%
0.00%0.0%
Q1 2021$428,000
+5.7%
11,390
-6.6%
0.00%0.0%
Q4 2020$405,000
+1.2%
12,200
+11.7%
0.00%0.0%
Q3 2020$400,000
-5.0%
10,920
-14.6%
0.00%0.0%
Q2 2020$421,000
+42.7%
12,790
+12.0%
0.00%0.0%
Q1 2020$295,000
+35.3%
11,423
+63.5%
0.00%
Q4 2019$218,0006,9860.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders